Engineers Gate Manager LP Sells 49,528 Shares of HCA Healthcare, Inc. $HCA

Engineers Gate Manager LP trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 81.2% in the second quarter, Holdings Channel.com reports. The firm owned 11,471 shares of the company’s stock after selling 49,528 shares during the quarter. Engineers Gate Manager LP’s holdings in HCA Healthcare were worth $4,472,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in HCA. Sumitomo Life Insurance Co. raised its holdings in shares of HCA Healthcare by 1.0% during the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after acquiring an additional 20 shares during the period. MJP Associates Inc. ADV raised its stake in shares of HCA Healthcare by 2.9% in the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after purchasing an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC boosted its position in shares of HCA Healthcare by 7.5% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after buying an additional 21 shares during the period. Anchyra Partners LLC raised its position in HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after buying an additional 21 shares during the last quarter. Finally, Moors & Cabot Inc. lifted its position in shares of HCA Healthcare by 2.5% in the fourth quarter. Moors & Cabot Inc. now owns 931 shares of the company’s stock worth $435,000 after purchasing an additional 23 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have commented on HCA shares. Jefferies Financial Group set a $450.00 price target on shares of HCA Healthcare in a research report on Tuesday, July 14th. The Goldman Sachs Group lowered their target price on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research report on Tuesday, July 28th. JPMorgan Chase & Co. decreased their price target on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a research note on Thursday, August 20th. Cantor Fitzgerald cut their price objective on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a report on Tuesday, July 7th. Finally, Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $462.64.

Get Our Latest Analysis on HCA Healthcare

HCA Healthcare Stock Up 1.5%

HCA Healthcare stock opened at $427.51 on Friday. The company’s 50-day moving average price is $404.99 and its two-hundred day moving average price is $433.41. The stock has a market cap of $92.56 billion, a P/E ratio of 14.31, a P/E/G ratio of 1.40 and a beta of 1.10. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.84 earnings per share. Equities analysts anticipate that HCA Healthcare, Inc. will post 29.42 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is 10.45%.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc (NYSE:HCA) is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.